Ara
Toplam kayıt 23, listelenen: 11-20
COVID-19 clinical course and blood groups: Turkish population-based study
(Tubitak Scientific & Technical Research Council Turkey, 2021)
Background/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 ...
Convalescent plasma therapy in patients with COVID-19
(Pergamon-Elsevier Science Ltd, 2021)
Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
Kronik Obstrüktif Akciğer Hastalığı Olan Hastalarda Kognitif Fonksiyonların Değerlendirilmesi
(Yerkure Tanitim & Yayincilik Hizmetleri A S, 2018)
Objective: Chronic obstructive pulmonary disease (COPD) is characterized with air flow limitation. Cognitive problems can appear in advanced stage of COPD. There is relationship between COPD and levels of homocystein (hcy) ...
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
(Springer-Verlag Italia Srl, 2022)
Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course ...
The outcome of COVID-19 in patients with hematological malignancy
(Wiley, 2021)
In this study, we aim to report the outcomes for COVID-19 in patients with hematological malignancy in Turkey. Data from laboratory-confirmed 188 897 COVID-19 patients diagnosed between 11 March 2020 and 22 June 2020 ...
The Diagnostic Utility of Flow Cytometry in Celiac Disease Presented Isolated Iron Deficiency Anemia
(Aves, 2021)
Background: Flow cytometric analysis of intestinal intraepithelial lymphocytes contributes to the diagnosis of celiac disease. Celiac disease may present with iron deficiency anemia alone which is considered as one of the ...
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
(Galenos Yayincilik, 2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
(Galenos Yayincilik, 2019)
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total ...
COVID-19 in hematopoietic cell transplant recipients
(Springernature, 2021)
In this study, we aim to report the outcome of COVID-19 in hematopoietic cell transplant (HCT) recipients. HCT recipients (n = 32) with hematological disease and hospitalized for COVID-19 were included in the study. A ...
Severe Immune Thrombocytopenia in Pregnancy Treated with Eltrombopag. A Case Report.
(2022)
Immune Thrombocytopenia (ITP) which is a common, acquired and autoimmune disease is defined as low platelet count secondary to increased platelet destruction or impaired thrombopoiesis by anti-thromboycte antibodies. ...